NEWPORT BEACH, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) -- via IBN -- , LLC (“ROTH”), announced today the addition of five ...

Nonfarm payrolls increased by 256,000 jobs last month after rising by a downwardly revised 212,000 in November, while the unemployment rate fell to 4.1% from 4.2%, Reuters reported this morning.

On second thought, the FDA figures it no longer needs to discuss Exelixis’ application for Cabometyx in neuroendocrine tumors ...

National American University Holdings Inc (NAUH) is expected to report for 2Q. Neogen Corp (NEOG) is expected to report $-0.01 for 2Q. NexImmune Inc (NEXI) is expected to report for 3Q.

Pharmaceuticals announced that it has commenced an underwritten public offering of shares of its common stock. Amylyx intends to ...

Amsterdam-based uniQure, a biotechnology company specialising in human gene-based therapies, recently announced its public offering of 4,411,764 ordinary ...

Uniqure N.V. (NASDAQ: QURE) has announced the pricing of its public offering of 4,411,764 ordinary shares at a price of ...

Leerink Partnrs analyst M. Cherny now forecasts that the medical research company will post earnings of $14.53 per share for ...

Leerink Partners has recently reduced CureVac BV (CVAC) stock to Market Perform rating, as announced on April 25, 2024, according to Finviz. Earlier, on June 8, 2023, SVB Securities had initiated the ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

Leerink Partners analyst Andrew Berens maintained a Hold rating on Agios Pharma (AGIO – Research Report) on January 6. The company’s shares ...

Fintel reports that on January 8, 2025, Leerink Partners downgraded their outlook for Accolade (NasdaqGS:ACCD) from ...